Inicio >> Signaling Pathways >> Apoptosis

Apoptosis

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade

Targets for  Apoptosis

Products for  Apoptosis

  1. Cat.No. Nombre del producto Información
  2. GC47042 Carfilzomib-d8

    Un estándar interno para la cuantificación de carfilzomib.

    Carfilzomib-d8  Chemical Structure
  3. GN10733 Carnosic acid Carnosic acid  Chemical Structure
  4. GC45679 Carubicin La carubicina (carminomicina) es un compuesto de origen microbiano. Carubicin  Chemical Structure
  5. GC64110 Carubicin hydrochloride El clorhidrato de carubicina es un compuesto derivado de microbios. Carubicin hydrochloride  Chemical Structure
  6. GC35612 Carvacrol Carvacrol es un fenol monoterpenoide aislado de Thymus mongolicus Ronn. Carvacrol  Chemical Structure
  7. GC62442 Casein Kinase inhibitor A51 El inhibidor de caseÍna quinasa A51 es un inhibidor potente y activo por vÍa oral de la caseÍna quinasa 1α (CK1α). El inhibidor de la caseÍna quinasa A51 induce la apoptosis de las células leucémicas y tiene potentes actividades antileucémicas. Casein Kinase inhibitor A51  Chemical Structure
  8. GC32841 Catechin ((+)-Catechin) La catequina ((+)-catequina) ((+)-catequina ((+)-catequina)) inhibe la ciclooxigenasa-1 (COX-1) con una IC50 de 1,4 μM. Catechin ((+)-Catechin)  Chemical Structure
  9. GN10543 caudatin caudatin  Chemical Structure
  10. GC43149 CAY10404 CAY10404 es un inhibidor potente y selectivo de la ciclooxigenasa-2 (COX-2) con una IC50 de 1 nM y un Índice de selectividad (SI; COX-1 IC50/COX-2 IC50) >500000. CAY10404  Chemical Structure
  11. GC43150 CAY10406 CAY10406 is a trifluoromethyl analog of an isatin sulfonamide compound that selectively inhibits caspases 3 and 7. CAY10406  Chemical Structure
  12. GC43154 CAY10443 Mitochondrial release of cytochrome c triggers apoptosis via the assembly of a multimeric complex including caspase-9, Apaf-1, and other components, sometimes called the apoptosome. CAY10443  Chemical Structure
  13. GC43176 CAY10575 CAY10575 (Compuesto 8) es un inhibidor de IKK2 con un IC50 de 0,075 μM. CAY10575  Chemical Structure
  14. GC18530 CAY10616 Resveratrol is a natural polyphenolic antioxidant that has anti-cancer properties. CAY10616  Chemical Structure
  15. GC41317 CAY10625 Survivin is a cellular protein implicated in cell survival by interacting with and inhibiting the apoptotic function of several proteins including Smac/DIABLO, caspase-3, and caspase-7. CAY10625  Chemical Structure
  16. GC43189 CAY10681 Inactivation of the tumor suppressor p53 commonly coincides with increased signaling through NF-κB in cancer. CAY10681  Chemical Structure
  17. GC43190 CAY10682 (±)-Nutlin-3 blocks the interaction of p53 with its negative regulator Mdm2 (IC50 = 90 nM), inducing the expression of p53-regulated genes and blocking the growth of tumor xenografts in vivo. CAY10682  Chemical Structure
  18. GC40650 CAY10706 CAY10706 is a ligustrazine-curcumin hybrid that promotes intracellular reactive oxygen species accumulation preferentially in lung cancer cells. CAY10706  Chemical Structure
  19. GC43198 CAY10717 CAY10717 is a multi-targeted kinase inhibitor that exhibits greater than 40% inhibition of 34 of 104 kinases in an enzymatic assay at a concentration of 100 nM. CAY10717  Chemical Structure
  20. GC43203 CAY10726 CAY10726 is an arylurea fatty acid. CAY10726  Chemical Structure
  21. GC46113 CAY10744 A topoisomerase II-α poison CAY10744  Chemical Structure
  22. GC47053 CAY10746 A ROCK1 and ROCK2 inhibitor CAY10746  Chemical Structure
  23. GC48392 CAY10747 An inhibitor of the Hsp90-Cdc37 protein-protein interaction CAY10747  Chemical Structure
  24. GC47055 CAY10749 CAY10749 (Compuesto 15) es un potente inhibidor PARP/PI3K con valores PIC50 de 8.22, 8.44, 8.25, 6.54, 8.13, 6.08 para PARP-1, PARP-2, PI3K⊵ ;, PI3K⋲ offlineefficient_models_2022q2.md.en_es_2021q4.mdCAY10749 is a highly effective anticancer compound targeted against a wide range of oncologic diseases.en_es_2021q4.md CAY10749  Chemical Structure
  25. GC47057 CAY10755 A fungal metabolite with anticancer activity CAY10755  Chemical Structure
  26. GC47061 CAY10763 A dual inhibitor of IDO1 and STAT3 activation CAY10763  Chemical Structure
  27. GC47065 CAY10773 A derivative of sorafenib CAY10773  Chemical Structure
  28. GC49080 CAY10786 CAY10786 (Compuesto 43) es un antagonista de GPR52 con un IC50 de 0,63 μM. CAY10786  Chemical Structure
  29. GC52245 CAY10792 An anticancer agent CAY10792  Chemical Structure
  30. GC14634 CBL0137 curaxin that activates p53 and inhibits NF-κB CBL0137  Chemical Structure
  31. GC15394 CBL0137 (hydrochloride) CBL0137 (clorhidrato) es un inhibidor de la histona chaperona, FACT. CBL0137 (clorhidrato) también puede activar p53 e inhibe NF-κB con EC50 de 0,37 y 0,47 µM, respectivamente. CBL0137 (hydrochloride)  Chemical Structure
  32. GC61636 CBR-470-2 CBR-470-2, un anÁlogo sustituido con glicina, puede activar la seÑalizaciÓn de NRF2. CBR-470-2  Chemical Structure
  33. GC13648 CC-223 CC-223 (CC-223) es un inhibidor potente, selectivo y biodisponible por vÍa oral de la cinasa mTOR, con un valor IC50 para la cinasa mTOR de 16 nM. CC-223 inhibe tanto mTORC1 como mTORC2. CC-223  Chemical Structure
  34. GC39169 CC-92480 CC-92480 (CC-92480), un fÁrmaco modulador de ubiquitina ligasa de cereblon E3 (CELMoD), actÚa como un pegamento molecular. CC-92480 muestra una alta afinidad por cereblon, lo que resulta en una potente actividad antimieloma. CC-92480  Chemical Structure
  35. GC19088 CC122 CC122 (CC 122) es un modulador de cerebro activo por vÍa oral. CC122  Chemical Structure
  36. GC61532 CCI-007 CCI-007 es una molécula pequeÑa con actividad citotÓxica contra la leucemia infantil con reordenamientos de MLL, con valores de IC50 de 2,5-6,2 μM en células sensibles. CCI-007  Chemical Structure
  37. GC12891 CCT007093 CCT007093 es un inhibidor eficaz de la proteÍna fosfatasa 1D (PPM1D Wip1). La inhibiciÓn de Wip1 puede activar la vÍa mTORC1 y mejorar la proliferaciÓn de hepatocitos después de la hepatectomÍa. CCT007093  Chemical Structure
  38. GC14566 CCT137690 An inhibitor of Aurora kinases and FLT3 CCT137690  Chemical Structure
  39. GC62561 CCT369260 CCT369260 (compuesto 1) es un inhibidor del linfoma 6 de células B activo por vÍa oral (BCL6) con actividad antitumoral. CCT369260 (compuesto 1) exhibe un IC50 de 520 nM. CCT369260  Chemical Structure
  40. GC33337 CDC801 CDC801 es una fosfodiesterasa 4 (PDE4) potente y activa por vÍa oral y factor de necrosis tumoral-α (TNF-α) inhibidor con IC50 de 1,1 μM y 2,5 μM, respectivamente. CDC801  Chemical Structure
  41. GC39555 CDDO-2P-Im CDDO-2P-Im es un anÁlogo de CDDO-imidazolida con efecto quimiopreventivo. CDDO-2P-Im puede reducir el tamaÑo y la gravedad de los tumores de pulmÓn en el modelo de cÁncer de pulmÓn de ratÓn. CDDO-2P-Im  Chemical Structure
  42. GC39556 CDDO-3P-Im CDDO-3P-Im es un anÁlogo de CDDO-imidazolida con efecto quimiopreventivo. CDDO-3P-Im puede reducir el tamaÑo y la gravedad de los tumores de pulmÓn en el modelo de cÁncer de pulmÓn de ratÓn. CDDO-3P-Im es un inhibidor de necroptosis activo por vÍa oral que se puede utilizar para la investigaciÓn de isquemia/reperfusiÓn (I/R). CDDO-3P-Im  Chemical Structure
  43. GC35629 CDDO-dhTFEA CDDO-dhTFEA (RTA dh404) es un compuesto triterpenoide de oleanano sintético que activa Nrf2 de forma potente e inhibe el factor de transcripciÓn proinflamatorio NF-κB. CDDO-dhTFEA  Chemical Structure
  44. GC35630 CDDO-EA CDDO-EA es un activador del elemento de respuesta antioxidante/factor 2 relacionado con NF-E2 (Nrf2/ARE). CDDO-EA  Chemical Structure
  45. GC32723 CDDO-Im (RTA-403) CDDO-Im (RTA-403) (RTA-403) es un activador de Nrf2 y PPAR, con Kis de 232 y 344 nM para PPARα y PPARγ. CDDO-Im (RTA-403)  Chemical Structure
  46. GC16625 CDDO-TFEA Nrf2 activator CDDO-TFEA  Chemical Structure
  47. GC43217 CDK/CRK Inhibitor CDK/CRK inhibitor is an inhibitor of cyclin-dependent kinases (CDK) and CDK-related kinases (CRK) with IC50 values ranging from 9-839 nM in vitro. CDK/CRK Inhibitor  Chemical Structure
  48. GC62596 CDK7-IN-3 CDK7-IN-3 (CDK7-IN-3) es un inhibidor de CDK7 no covalente, altamente selectivo, activo por vÍa oral con una KD de 0,065 nM. CDK7-IN-3 muestra una inhibiciÓn pobre de CDK2 (Ki=2600 nM), CDK9 (Ki=960 nM), CDK12 (Ki=870 nM). CDK7-IN-3 induce apoptosis en células tumorales y tiene actividad antitumoral. CDK7-IN-3  Chemical Structure
  49. GC35636 CDK9-IN-7 CDK9-IN-7 (compuesto 21e) es un inhibidor de CDK9/ciclina T selectivo, muy potente y activo por vÍa oral (IC50=11 nM), que muestra una mayor potencia que otras CDK (CDK4/ciclinaD=148 nM; CDK6/ciclinaD= 145 nM). CDK9-IN-7 muestra actividad antitumoral sin toxicidad evidente. CDK9-IN-7 induce la apoptosis de las células NSCLC, detiene el ciclo celular en la fase G2 y suprime las propiedades de tallo del NSCLC. CDK9-IN-7  Chemical Structure
  50. GC19096 CDKI-73 CDKI-73 (LS-007) es un inhibidor de CDK9 muy eficaz y activo por vÍa oral, con valores de Ki de 4 nM, 4 nM y 3 nM para CDK9, CDK1 y CDK2, respectivamente. CDKI-73  Chemical Structure
  51. GC61865 Cearoin La cearoÍna aumenta la autofagia y la apoptosis a través de la producciÓn de ROS y la activaciÓn de ERK. Cearoin  Chemical Structure
  52. GC15083 Celastrol A triterpenoid antioxidant Celastrol  Chemical Structure
  53. GC49152 Celecoxib Carboxylic Acid An inactive metabolite of celecoxib Celecoxib Carboxylic Acid  Chemical Structure
  54. GC47070 Celecoxib-d7 An internal standard for the quantification of celecoxib Celecoxib-d7  Chemical Structure
  55. GC18392 Cellocidin Cellocidin is an antibiotic originally isolated from S. Cellocidin  Chemical Structure
  56. GN10113 Cepharanthine Cepharanthine  Chemical Structure
  57. GC52489 Ceramide (hydroxy) (bovine spinal cord) A sphingolipid Ceramide (hydroxy) (bovine spinal cord)  Chemical Structure
  58. GC52485 Ceramide (non-hydroxy) (bovine spinal cord) A sphingolipid Ceramide (non-hydroxy) (bovine spinal cord)  Chemical Structure
  59. GC52486 Ceramide Phosphoethanolamine (bovine) A sphingolipid Ceramide Phosphoethanolamine (bovine)  Chemical Structure
  60. GC43229 Ceramide Phosphoethanolamines (bovine) Ceramide phosphoethanolamine (CPE) is an analog of sphingomyelin that contains ethanolamine rather than choline as the head group. Ceramide Phosphoethanolamines (bovine)  Chemical Structure
  61. GC47073 Ceramides (hydroxy) A mixture of hydroxy fatty acid-containing ceramides Ceramides (hydroxy)  Chemical Structure
  62. GC43230 Ceramides (non-hydroxy) Ceramides are generated from sphingomyelin through activation of sphingomyelinases or through the de novo synthesis pathway, which requires the coordinated action of serine palmitoyl transferase and ceramide synthase. Ceramides (non-hydroxy)  Chemical Structure
  63. GC49706 Cerberin A cardiac glycoside with cytotoxic and cardiac modulatory activities Cerberin  Chemical Structure
  64. GC60688 Cereblon modulator 1 Cereblon modulator 1 (CC-90009) es un modulador de ligasa E3 de cereblon (CRBN) selectivo para GSPT1, el primero en su clase, que actÚa como un pegamento molecular. Cereblon modulator 1  Chemical Structure
  65. GC65487 Certolizumab pegol

    Certolizumab pegol (Certolizumab) es un fragmento de anticuerpo monoclonal humanizado recombinante, polietilenglicolilado y de unión a antígenos que se dirige selectivamente y neutraliza el factor de necrosis tumoral-α (TNF-α).

    Certolizumab pegol  Chemical Structure
  66. GC11543 Cesium chloride Cesium chloride  Chemical Structure
  67. GC11710 CFM 4 CFM 4 es un potente antagonista molecular pequeÑo de la uniÓn de CARP-1/APC-2. CFM 4 evita la uniÓn de CARP-1 con APC-2, provoca la detenciÓn del ciclo celular G2M e induce la apoptosis con un intervalo de IC50 de 10-15 μM. CFM 4 también suprime el crecimiento de células de cÁncer de mama humano resistentes a los medicamentos. CFM 4  Chemical Structure
  68. GC35668 CG-200745 CG-200745 (CG-200745) es un potente inhibidor pan-HDAC activo por vÍa oral que tiene la fracciÓn de Ácido hidroxÁmico para unirse al zinc en la parte inferior de la bolsa catalÍtica. CG-200745 inhibe la desacetilaciÓn de histona H3 y tubulina. CG-200745 induce la acumulaciÓn de p53, promueve la transactivaciÓn dependiente de p53 y mejora la expresiÓn de las proteÍnas MDM2 y p21 (Waf1/Cip1). CG-200745 mejora la sensibilidad de las células resistentes a la gemcitabina a la gemcitabina y al 5-fluorouracilo (5-FU; ). CG-200745 induce apoptosis y tiene efectos antitumorales. CG-200745  Chemical Structure
  69. GC10666 CGP 57380 CGP 57380 es un compuesto de pirazolo-pirimidina permeable a las células que actÚa como un inhibidor selectivo de Mnk1 con IC50 de 2,2 μM, pero no tiene actividad inhibidora contra p38, JNK1, ERK1/2, PKC o quinasas similares a Src. CGP 57380  Chemical Structure
  70. GC43234 Chaetoglobosin A La quetoglobosina A, el principio activo del extracto de Penicillium aquamarinium, es miembro de la familia de las citocalasanas. Chaetoglobosin A  Chemical Structure
  71. GC18536 Chartreusin Chartreusin is an antibiotic originally isolated from S. Chartreusin  Chemical Structure
  72. GN10463 Chelerythrine Chelerythrine  Chemical Structure
  73. GC13065 Chelerythrine Chloride Potent inhibitor of PKC and Bcl-xL Chelerythrine Chloride  Chemical Structure
  74. GC31886 Chelidonic acid El Ácido quelidÓnico es un componente de Chelidonium majus L. Chelidonic acid  Chemical Structure
  75. GC40878 Chelidonine Chelidonine es un alcaloide de isoquinolina, se puede aislar de Chelidonium majus L. Chelidonine  Chemical Structure
  76. GC43236 Chevalone B Chevalone B is a meroterpenoid originally isolated from the fungus E. Chevalone B  Chemical Structure
  77. GC43237 Chevalone C Chevalone C, un metabolito fÚngico meroterpenoide, muestra actividad antipalÚdica con un valor IC50 de 25,00 μg/mL. Chevalone C  Chemical Structure
  78. GC64993 Chicoric acid El Ácido chicorico (Ácido cicÓrico), un Ácido dicaffeyltartarico activo por vÍa oral, induce la generaciÓn de especies reactivas de oxÍgeno (ROS). Chicoric acid  Chemical Structure
  79. GC15739 CHIR-124 CHIR-124 es un inhibidor potente y selectivo de Chk1 con IC50 de 0,3 nM, y también se dirige potentemente a PDGFR y FLT3 con IC50 de 6,6 nM y 5,8 nM. CHIR-124  Chemical Structure
  80. GC43239 Chk2 Inhibitor El inhibidor de Chk2 (compuesto 1) es un inhibidor potente y selectivo de la quinasa de punto de control 2 (Chk2), con IC50 de 13,5 nM y 220,4 nM para Chk2 y Chk1, respectivamente. El inhibidor de Chk2 puede provocar un fuerte efecto de radioprotecciÓn mediado por Chk2 dependiente de ataxia telangiectasia mutada (ATM). Chk2 Inhibitor  Chemical Structure
  81. GC45717 Chlamydocin La clamidocina, un metabolito fÚngico, es un inhibidor de HDAC muy potente, con una IC50 de 1,3 nM. La clamidocina exhibe potentes actividades antiproliferativas y anticancerÍgenas. La clamidocina induce la apoptosis al activar la caspasa-3. Chlamydocin  Chemical Structure
  82. GC17969 CHM 1 An inhibitor of tubulin polymerization CHM 1  Chemical Structure
  83. GC35682 CHMFL-ABL/KIT-155 CHMFL-ABL/KIT-155 (CHMFL-ABL-KIT-155; compuesto 34) es un inhibidor dual de la cinasa ABL/c-KIT de tipo II altamente potente y activo por vÍa oral (CI50 de 46 nM y 75 nM, respectivamente), y también presenta actividades inhibitorias significativas para BLK (IC50=81 nM), CSF1R (IC50=227 nM), DDR1 (IC50=116 nM), DDR2 (IC50=325 nM), LCK (IC50=12 nM) y PDGFRβ (IC50= 80 nM) quinasas. CHMFL-ABL/KIT-155 (CHMFL-ABL-KIT-155) detiene la progresiÓn del ciclo celular e induce la apoptosis. CHMFL-ABL/KIT-155  Chemical Structure
  84. GC64028 Chrysosplenol D El crisosplenol D es un metoxiflavonoide que induce la apoptosis mediada por ERK1/2 en células de cÁncer de mama humano triple negativas. Chrysosplenol D  Chemical Structure
  85. GC13408 CI994 (Tacedinaline) An inhibitor of HDAC1, -2, and -3 CI994 (Tacedinaline)  Chemical Structure
  86. GC13589 CID 755673 CID 755673 es un potente inhibidor de PKD con IC50 de 182 nM, 280 nM y 227 nM para PKD1, PKD2 y PKD3, respectivamente. CID 755673  Chemical Structure
  87. GC19436 CID-5721353 CID-5721353 es un inhibidor de BCL6 con un valor IC50 de 212 μM, lo que corresponde a una Ki de 147 μM. CID-5721353  Chemical Structure
  88. GC32997 Cinchonine ((8R,9S)-Cinchonine) Cinchonine ((8R,9S)-Cinchonine) es un compuesto natural presente en la corteza de Cinchona. La cinconina ((8R,9S)-cinchonina) activa la apoptosis inducida por estrés del retÍculo endoplÁsmico en células de cÁncer de hÍgado humano. Cinchonine ((8R,9S)-Cinchonine)  Chemical Structure
  89. GC60708 Cinchonine hydrochloride El clorhidrato de cinconina ((8R,9S)-clorhidrato de cinconina) es un alcaloide natural presente en la corteza de cinconina, con actividad antipalÚdica. El clorhidrato de cinconina activa la apoptosis inducida por estrés del retÍculo endoplÁsmico (ER) en células de cÁncer de hÍgado humano. Cinchonine hydrochloride  Chemical Structure
  90. GC52269 Cinnabarinic Acid-d4 An internal standard for the quantification of cinnabarinic acid Cinnabarinic Acid-d4  Chemical Structure
  91. GC40986 Cinnamamide Cinnamamide is an amide form of of trans-cinnamic acid and a metabolite of Streptomyces. Cinnamamide  Chemical Structure
  92. GN10189 Cinobufagin Cinobufagin  Chemical Structure
  93. GC11908 Cisplatin Cisplatin actualmente es uno de los mejores y primeros medicamentos de quimioterapia que base de metales, y se han utilizado ampliamente en cáncer sólido, como dídimo, vejiga, pulmón, cuello uterino, cabeza y cuello, estómago, etc. Cisplatin  Chemical Structure
  94. GC17491 CITCO CITCO, un derivado de imidazotiazol, es un agonista selectivo del receptor de androstano constitutivo (CAR). CITCO inhibe el crecimiento y la expansiÓn de las células madre de tumores cerebrales (BTSC) y tiene una EC50 de 49nM sobre el receptor X de pregnano (PXR) y no tiene actividad sobre otros receptores nucleares. CITCO  Chemical Structure
  95. GC35703 Citicoline La citicolina (citidina difosfato-colina) es un intermediario en la sÍntesis de fosfatidilcolina, un componente de las membranas celulares. Citicoline  Chemical Structure
  96. GC31186 Citicoline sodium salt

    El citicolina sal sódica es un intermediario en la síntesis de fosfatidilcolina, que es un componente de las membranas celulares y también ejerce efectos neuroprotectores.

    Citicoline sodium salt  Chemical Structure
  97. GC43273 Citreoindole Citreoindole is a diketopiperazine metabolite isolated from a hybrid cell fusion of two strains of P. Citreoindole  Chemical Structure
  98. GC41514 Citreoviridin Citreoviridina, una toxina de Penicillium citreoviride NRRL 2579, inhibe la Na+/K+-ATPasa sinaptosÓmica cerebral mientras que en los microsomas, tanto la Na+/K+-ATPasa como la Mg2+-ATPasa son significativamente estimulados de una manera dependiente de la dosis. Citreoviridin  Chemical Structure
  99. GC14203 Citric acid El Ácido cÍtrico es un conservante natural y potenciador de la acidez de los alimentos. Citric acid  Chemical Structure
  100. GC68051 Citric acid-d4 Citric acid-d4  Chemical Structure
  101. GC16661 Citrinin

    Un micotoxina que induce apoptosis.

    Citrinin  Chemical Structure

Artículos 501 al 600 de 2214 totales

por página
  1. 4
  2. 5
  3. 6
  4. 7
  5. 8

Fijar Dirección Descendente